Your browser doesn't support javascript.
loading
Late-onset Hypogonadism and Testosterone Therapy - A Summary of Guidelines from the American Urological Association and the European Association of Urology.
Fode, Mikkel; Salonia, Andrea; Minhas, Suks; Burnett, Arthur L; Shindel, Alan W.
Afiliação
  • Fode M; Department of Urology, Herlev and Gentofte Hospital, Herlev, Denmark. Electronic address: mikkel.mejlgaard.fode@regionh.dk.
  • Salonia A; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy.
  • Minhas S; Imperial College Healthcare, NHS Trust, London, UK.
  • Burnett AL; The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Shindel AW; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
Eur Urol Focus ; 5(4): 539-544, 2019 Jul.
Article em En | MEDLINE | ID: mdl-30858073
ABSTRACT
Men with low serum testosterone and symptoms of androgen deficiency may be diagnosed with testosterone deficiency. This condition is associated with metabolic syndrome and cardiovascular disease. The benefits (eg, improvement in sexual function) and risks (eg, prostate cancer and cardiovascular disease) of testosterone therapy are controversial. The American Urological Association and European Association of Urology guidelines on testosterone therapy differ on several points of management, likely reflecting the ambiguities surrounding testosterone therapy in practice. This paper summarizes both guidelines with a focus on the differences between the two sets of guidelines. PATIENT

SUMMARY:

The benefits and risks of testosterone therapy are controversial, as reflected in the European Association of Urology and American Urological Association guidelines that differ on several points of management.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Testosterona / Hipogonadismo Tipo de estudo: Guideline / Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Revista: Eur Urol Focus Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Testosterona / Hipogonadismo Tipo de estudo: Guideline / Risk_factors_studies Limite: Adult / Humans / Male Idioma: En Revista: Eur Urol Focus Ano de publicação: 2019 Tipo de documento: Article